MedPath

Comparison of Two Protocols of Misoprostol (PGE1) and the Rate of Cesarean Section Due to Failed Induction.

Not Applicable
Completed
Conditions
Induction of Labor
Registration Number
NCT03489798
Lead Sponsor
Saint Thomas Hospital, Panama
Brief Summary

To compare two protocols of misoprostol use for cervical ripening: 3 doses (25 ug vaginal each) or up to six doses, every six hours, until an adequate cervical condititon was achieved (BIshop score \> 6). In the first group, after 3 doses, the patient was sent to the delivery room for induction with oxytocin and in case of failure, a cesarean section was indicated for this reason. In the second group, up to six doses were used in a similar fashion. Rates of success were evaluated, as well as maternal and fetal complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
310
Inclusion Criteria
  • Pregnant women between 34 and 42 weeks of gestation.
  • Obstetric indication for termination of pregnancy.
  • No fetal evidence of fetal distress
Exclusion Criteria
  • Any contraindication for the use of misoprostol.
  • Oligohydramnios.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Vaginal birth48 hours

Number of patients that had a vaginal birth

Secondary Outcome Measures
NameTimeMethod
Maternal complications48 hours

Number of patients that developed a maternal complication due to the use of misoprostol (abruptio placenta, postpartum bleeding, uterine atony).

Fetal complications48 hours

Number of patients that developed a fetal complication due to the use of misoprostol (stillbirth, fetal distress).

Trial Locations

Locations (1)

Saint Thomas Maternity Hospital

🇵🇦

Panama, Panama

Saint Thomas Maternity Hospital
🇵🇦Panama, Panama

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.